Literature DB >> 16897649

Initial treatment of HIV infection: randomized trials with clinical end points are still needed.

Michael D Hughes.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16897649     DOI： 10.1086/506369

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  9 in total

1.  Influence of Substance Use Disorders on 2-Year HIV Care Retention in the United States.

Authors:  Bryan Hartzler; Julia C Dombrowski; Jason R Williams; Heidi M Crane; Joseph J Eron; Elvin H Geng; Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan
Journal:  AIDS Behav       Date:  2018-03

2.  AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics.

Authors:  Marlene Smurzynski; Ann C Collier; Susan L Koletar; Ronald J Bosch; Kunling Wu; Barbara Bastow; Constance A Benson
Journal:  HIV Clin Trials       Date:  2008 Jul-Aug

3.  Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana.

Authors:  C William Wester; Ann Muir Thomas; Hermann Bussmann; Sikhulile Moyo; Joseph M Makhema; Tendani Gaolathe; Vladimir Novitsky; Max Essex; Victor deGruttola; Richard G Marlink
Journal:  AIDS       Date:  2010-01       Impact factor: 4.177

4.  Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States.

Authors:  Bryan Hartzler; Julia C Dombrowski; Heidi M Crane; Joseph J Eron; Elvin H Geng; W Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan
Journal:  AIDS Behav       Date:  2017-04

5.  Identifying HIV care enrollees at-risk for cannabis use disorder.

Authors:  Bryan Hartzler; Beatriz H Carlini; Howard Newville; Heidi M Crane; Joseph J Eron; Elvin H Geng; W Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan
Journal:  AIDS Care       Date:  2016-12-23

6.  Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.

Authors:  Hermann Bussmann; C William Wester; Ann Thomas; Vladimir Novitsky; Reginald Okezie; Tanaka Muzenda; Tendani Gaolathe; Ndwapi Ndwapi; Norah Mawoko; Erik Widenfelt; Sikhulile Moyo; Rosemary Musonda; Madisa Mine; Joseph Makhema; Howard Moffat; Max Essex; Victor Degruttola; Richard G Marlink
Journal:  J Acquir Immune Defic Syndr       Date:  2009-05-01       Impact factor: 3.731

7.  Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

Authors:  Michael J Mugavero; Margaret May; Ross Harris; Michael S Saag; Dominique Costagliola; Matthias Egger; Andrew Phillips; Huldrych F Günthard; Francois Dabis; Robert Hogg; Frank de Wolf; Gerd Fatkenheuer; M John Gill; Amy Justice; Antonella D'Arminio Monforte; Fiona Lampe; Jose M Miró; Schlomo Staszewski; Jonathan A C Sterne
Journal:  AIDS       Date:  2008-11-30       Impact factor: 4.177

8.  Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.

Authors:  Alan R Lifson; Waldo H Belloso; Richard T Davey; Daniel Duprez; Jose M Gatell; Jennifer F Hoy; Eric A Krum; Ray Nelson; Court Pedersen; George Perez; Richard W Price; Ronald J Prineas; Frank S Rhame; James H Sampson; John Worley
Journal:  HIV Clin Trials       Date:  2010 Jul-Aug

9.  Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems.

Authors:  Mari M Kitahata; Benigno Rodriguez; Richard Haubrich; Stephen Boswell; W Christopher Mathews; Michael M Lederman; William B Lober; Stephen E Van Rompaey; Heidi M Crane; Richard D Moore; Michael Bertram; James O Kahn; Michael S Saag
Journal:  Int J Epidemiol       Date:  2008-02-08       Impact factor: 7.196
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.